APOA1 and neoplasm: Apolipoprotein A-I, the major component of high-density lipoproteins, binds to its main receptor, SR-BI, which is overexpressed on liver and tumour cells, thereby effectively targeting IL-15 activity within the recombinant protein to the tumour.52–54